Key facts
- It has raised $10.4M; the latest was Later Stage VC in Jan 2026.
- Notable investors include China Taiping Investment, Guangzhou Guangyao Capital, Huafa Group, Motianshi Investment, Livzon Pharmaceutical Group.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for MedPHA
- ·The full record, as it builds
Funding rounds
No funding rounds for MedPHA are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About MedPHA
Manufacturer of electronic specialty gases and precursors intended for semiconductor, display panel and photovoltaic industries. The company's range of products includes hydrogen bromide, boron trichloride, ethylene, acetylene, propylene, propane, diiodosilane and tungsten pentachloride, thereby supporting ultra-large-scale integrated circuit manufacturing and exports to global markets.
- Sector
- Healthcare
- HQ
- Zhuhai, China
- Founded
- 2019
- Employees
- 15
- Website
- medpha.cn/
- Ownership
- Privately Held (backing)
MedPHA doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in MedPHA shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on MedPHA in its N-PORT filings yet. We sweep new filings monthly.